Inventor · disambiguated record
Vincent Lotteau
Also filed as: LOTTEAU VINCENT
10 granted patents·15 pending applications·107 citations·filing 1999–2021
87Inventor score
Top patents by PatentIndex Score
25 records- 0195US9695446B2Direct protein delivery with engineered microvesiclesINSERM (INSTITUT NAT DE LA SANTE ET DE LA RECH MEDICALE)·Filed 2014·Granted Jul 4, 2017·46 cites·16 claims
- 0293US8697439B2Direct protein delivery with engineered microvesiclesMANGEOT PHILIPPE·Filed 2010·Granted Apr 15, 2014·28 cites·5 claims
- 0380US9895380B2Methods and pharmaceutical compositions for the treatment of hepatitis B virus infectionINST NAT SANTE RECH MED·Filed 2014·Granted Feb 20, 2018·5 cites·9 claims
- 0474US6548295B2Complex of lipo-viro-particles, method of preparation and applicationsBIO MERIEUX·Filed 2001·Granted Apr 15, 2003·7 cites·27 claims
- 0564US6506555B1Use of HIV protease inhibiting compoundsINST NAT SANTE RECH MED·Filed 1999·Granted Jan 14, 2003·21 cites·4 claims
- 0660US2008176820A1Use of L-alpha-lysophosphatidylcholine to obtain the differentiation of monocytes into mature dendritic cells in vitroBIOMERIEUX SA·Filed 2008·Application pending·0 cites
- 0754US7368287B2Use of L-α-lysophosphatidylcholine to obtain the differentiation of monocytes into mature dendritic cells in vitroBIOMERIEUX SA·Filed 2003·Granted May 6, 2008·0 cites·5 claims
- 0853US10071108B2Methods and pharmaceutical compositions for the treatment of hepatitis b virus infectionINST NAT SANTE RECH MED·Filed 2018·Granted Sep 11, 2018·0 cites·16 claims
- 0952US2023060715A1Use of fxr agonists for treating an infection by hepatitis d virusINST NAT SANTE RECH MED·Filed 2021·Application pending·0 cites
- 1051US2014356943A1Reprogrammation of Eukaryotic Cells with Engineered MicrovesiclesINST NAT SANTE RECH MED·Filed 2014·Application pending·0 cites
- 1150US2011135684A1Use of L-alpha-lysophosphatidylcholine to obtain the differentiation of monocytes in mature dendritic cells in vitroBIOMERIEUX SA·Filed 2011·Application pending·0 cites
- 1249US2005221464A1Method for culturing hcv virus in vitroBIOMERIEUX SA·Filed 2003·Application pending·0 cites
- 1349US2011091994A1Methods for Screening Compounds for Treating and/or Preventing an Hepatitis C Virus InfectionINSERM INST NAT DE LA SANTA ET DE LA RECH MEDICALE·Filed 2009·Application pending·0 cites
- 1447US8716020B2Reprogrammation of eukaryotic cells with engineered microvesiclesMANGEOT PHILIPPE·Filed 2010·Granted May 6, 2014·0 cites·7 claims
- 1547US2021085662A1Methods and pharmaceutical compositions for reducing persistence and expression of episomal virusesINST NAT SANTE RECH MED·Filed 2018·Application pending·0 cites
- 1646US2023181539A1Methods for the treatment of coronavirus infectionsINST NAT SANTE RECH MED·Filed 2021·Application pending·0 cites
- 1746US2004229336A1Method for in vitro culture of viruses of the togaviridae and flaviviridae families and usesBIO MERIEUX·Filed 2004·Application pending·0 cites
- 1846US2023146096A1Use of vidofludimus for the treatment of coronavirus infectionsINST NAT SANTE RECH MED·Filed 2021·Application pending·0 cites
- 1945US2010172870A1Methods, uses and compositions for modulating replication of hcv through the farnesoid x receptor (fxr) activation or inhibitionANDRE PATRICE·Filed 2007·Application pending·0 cites
- 2043US9168236B2Methods and pharmaceutical compositions for inhibiting influenza viruses replicationLOTTEAU VINCENT·Filed 2012·Granted Oct 27, 2015·0 cites·10 claims
- 2143US2003082207A1Method of using HIV protease inhibiting compoundsFiled 2002·Application pending·0 cites
- 2242US7259012B2Use of oxidized lipoproteins for differentiation of precursor cells into mature dendritic cellsINST NAT SANTE RECH MED·Filed 2002·Granted Aug 21, 2007·0 cites·20 claims
- 2338US2016250245A1Methods and Pharmaceutical Composition for the Treatment of Polyomavirus InfectionsINSERM (INSTITUT NAT DE LA SANTÉ ET DE LA RECH MÉDICALE·Filed 2014·Application pending·0 cites
- 2436US2014296106A1Methods for screening substances capable of modulating the replication of an influenza virusINSERM INST NAT DE LA SANTÉ ET DE LA RECH MÉDICALE·Filed 2012·Application pending·0 cites
- 2529US2014024101A1Method for increasing the replication capacity of an influenza virus in cultured cellsLOTTEAU VINCENT·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Vincent Lotteau files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →